Through this C-19 impacted period ASB has reiterated EBIT guidance of at least $110m, however surprised to the upside today with an upgrade to $125m+. The Company highlighted continued strong performance across the group’s operations and we think the weaker AUD has also provided a significant tailwind. Our forecasts beyond FY21 are unchanged at this point and we remain positive on opportunities to add to the order book in the longer term. We maintain a BUY call on an unchanged $3.70 valuation.
To access the full report please log in under the Client Area at the bottom of this page.
Argonaut’s Client Area allows you to view delayed share prices, access Argonaut’s wealth of Research as well as create custom portfolios and set up company watch lists.
If you would like to access our research please contact us to create an account.
